GSK (GSK)

1,486.00p

17:10 25/03/25

  • 0.07% 1.00p
  • Today's Low & High
  • 1,485.50 / 1,512.50
  • Open / Previous Close
  • 1,487.50 / 1,486.00
  • 52-week range
  • -12.31% -208.60p
  • Volume
  • 8,803,687
  • Market Cap(million)
  • £61,403.12m

KEY FINANCIALS

  Latest Forecast
Div Yield 4.1% 4.4%
Div Cover 2.6 2.6
Op Mrgn 12.8% 28.4%
ROCE 47.1%  
  Latest Forecast
P/E 9.3 0.0
PEG 3.4 2.7
Price / Revenue 2.0 1.8
Price / Book value 4.7  
  Latest Forecast
Revenue 3.5% -2.2%
PBT -42.7% n/a
EPS 2.7% -6.1%
DPS 5.2% -2.1%

KEY FUNDAMENTALS

Year Ending Revenue
(£m)		 Pre-tax
(£m)		 EPS P/E PEG EPS Growth Div Yield
2020-12-31 34,099.00 6,968.00 115.90p 14.5 -2.2 -6% 80.00p 4.8%
2021-12-31 24,696.00 3,599.00 90.56p 22.2 -1.0 -22% 80.00p 4.0%
2022-12-31 29,324.00 5,628.00 139.70p 10.3 0.2 54% 44.00p 3.1%
2023-12-31 30,328.00 6,064.00 155.10p 9.4 0.8 11% 58.00p 4.0%
2024-12-31 31,376.00 3,477.00 159.30p 8.5 3.1 3% 61.00p 4.5%

Latest Webfg News

EMA accepts GSK's application to expand Nucala use Sharecast News 24 Mar
FDA to review GSK's depemokimab Sharecast News 03 Mar
London close: Stocks little changed after UK data dump Sharecast News 21 Feb

Regulatory News

GSK uUTI treatment approved by US FDA 25-Mar-25 22:57
Transaction in Own Shares 25-Mar-25 22:55
Notice of AGM 24-Mar-25 16:10
EMA Filing acceptance for Nucala COPD 24-Mar-25 07:05
Transaction in Own Shares 24-Mar-25 07:01